Alvotech (ALVO) Revenue History
Annual and quarterly revenue from 2020 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
ALVO Revenue Growth
Revenue Breakdown (FY 2023)
ALVO's revenue distribution by segment and geography for fiscal year 2023
By Product/Segment
By Geography
ALVO Revenue Analysis (2020–2025)
As of May 8, 2026, Alvotech (ALVO) generated trailing twelve-month (TTM) revenue of $586.3 million, reflecting strong growth of +10.0% year-over-year. The most recent quarter (Q4 2025) recorded $166.4 million in revenue, up 46.0% sequentially.
Looking at the longer-term picture, ALVO's 5-year compound annual growth rate (CAGR) stands at +54.5%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $586.3 million in 2025, representing a new all-time high.
Revenue diversification analysis shows ALVO's business is primarily driven by Humira (100%). With over half of revenue concentrated in Humira, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including AMGN (+9.1% YoY), TEVA (+4.4% YoY), and VTRS (+1.6% YoY), ALVO has outperformed the peer group in terms of revenue growth. Compare ALVO vs AMGN →
ALVO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ALVOCurrent | $586M | +10.0% | +54.5% | 13.3% | |
 AMGN | $36.7B | +9.1% | +7.6% | 29.1% | |
 TEVA | $17.3B | +4.4% | +0.7% | 12.5% | |
 VTRS | $14.3B | +1.6% | +3.7% | -18.6% | |
 ABBV | $61.2B | +8.6% | +6.0% | 32.8% | |
 JNJ | $88.8B | +3.7% | +1.6% | 24.9% |
ALVO Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $586.3M | +19.7% | $350.8M | 59.8% | $78.2M | 13.3% |
| 2024 | $489.7M | +435.6% | $304.4M | 62.2% | $69.6M | 14.2% |
| 2023 | $91.4M | +10.1% | $-69,422,000 | -75.9% | $-354,860,000 | -388.1% |
| 2022 | $83.0M | +125.8% | $18.9M | 22.8% | $-346,442,000 | -417.3% |
| 2021 | $36.8M | -44.8% | $36.8M | 100.0% | $-235,456,000 | -640.3% |
| 2020 | $66.6M | - | $66.6M | 100.0% | $-137,537,000 | -206.5% |
See ALVO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ALVO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ALVO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonALVO — Frequently Asked Questions
Quick answers to the most common questions about buying ALVO stock.
Is ALVO's revenue growth accelerating or slowing?
ALVO maintains +10.0% revenue growth, in line with its 5-year CAGR of +54.5%. TTM revenue stands at $586M. Growth rate remains consistent with historical average.
What is ALVO's long-term revenue growth rate?
Alvotech's 5-year revenue CAGR of +54.5% reflects the sustained expansion pattern. Current YoY growth of +10.0% is near this long-term average.
How is ALVO's revenue distributed by segment?
ALVO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2025 are available for download. Segment mix reveals concentration and diversification trends.